Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, June 19, 2013
Technology Networks
 
Register | Sign in
Home Page
  News

Possible Clues Found to why HIV Vaccine Showed Modest Protection

Published: Friday, April 06, 2012
Last Updated: Friday, April 06, 2012
Bookmark and Share
Analysis by NIH-supported scientists may help identify requirements for HIV vaccine.

Full access to this article is for registered users only.
Registration is free-of-charge and allows access to all content on our web communities.

Already registered? Then please log in at the top of the page.

Print Page

Scientific News
Experimental Vaccine Shows Promise against TB Meningitis
Study in animals lays groundwork for new prevention strategies in brain TB.
New Way to Improve Antibiotic Production
A discovery has been made which could make it easier to scale up antibiotic production for commercialisation.
Researchers Pioneer Treatment for Viral Infection Common in Children
Professor Peter Openshaw and team develops a new technique used in tackling a wide range of other diseases.
Racial and Economic Gap in Awareness of Lifesaving HPV Vaccine
Research finds worrisome racial, economic, educational, and gender gaps in awareness about the lifesaving vaccine for HPV.
Retrogenix Points to New Drug Target for Malaria in Children
The discovery reported this week in Nature.
Results of the ROTAVAC Rotavirus Vaccine Study in India
Statement of Anthony S. Fauci, M.D. Director, National Institute of Allergy and Infectious Diseases National Institutes of Health.
BBSRC is Major Partner in Europe-wide Synthetic Biology Funding
BBSRC is contributing €3M as a major partner in a new call for research projects in Synthetic Biology.
Cobra Biologics and Vaccibody Sign Agreement to Manufacture DNA Vaccine
Companies announce agreement to manufacture Vaccibody’s lead DNA vaccine candidate against HPV-induced malignancies.
Cocaine Vaccine Passes Key Testing Hurdle
New anti-cocaine vaccine research shows drug can't reach the brain, human clinical trials on the horizon.
Vectura Establishes Strategic Partnership (Kinnovata) for New Respiratory Business in China
Kinnovata to commercialise products in fast growing Asian respiratory markets.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to ePosters.net